Regulated Information
Financial Reports
06
May
2022
Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights
05
Aug
2022
Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlights
SEC Filings
Filter
Filing Date | Form | Description | Filing Group | Downloads |
---|---|---|---|---|
March 24, 2023 | 6-K | Report of Foreign Issuer: Celyad Oncology appoints Georges Rawadi as its new CEO | Current reports | |
March 23, 2023 | 20-F | Annual and Transition Report (foreign private issuer): Annual Report 2022 | Current reports | |
March 23, 2023 | 6-K | Report of foreign issuer: Celyad Oncology reports full year 2022 financial results and recent business highlights | ||
March 16, 2023 | 6-K | Report of foreign issuer: Celyad Oncology announces non-cash impairment | Current reports | |
March 9, 2023 | 6-K | Report of Foreign Issuer: Letter to Shareholders | Current reports | |
February 3, 2023 | 6-K | Celyad Oncology provides fourth quarter 2022 business update and 2023 outlook |